SCHEMBL4037113

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4036465	0.83	CLK2 (0.57)	RETFGFR1FLT1KDRPDGFRA
	SCHEMBL4035837	0.81	KDR (0.67)	RETFGFR1FLT1KDRPDGFRA
	SCHEMBL31006231	0.80	FGFR1 (0.66)	RETFGFR1FLT1KDRPDGFRA
	SCHEMBL4038126	0.80	RET (0.69)	RETFGFR1FLT1KDRPDGFRA
	SCHEMBL4042919	0.79	RET (0.59)	RETFGFR1FLT1KDRPDGFRA
	SCHEMBL4038916	0.79	RET (0.68)	RETKDRERBB2CDK1
	SCHEMBL4033966	0.79	RET (0.70)	RETFGFR1FLT1KDRERBB2
	SCHEMBL4036833	0.78	RET (0.70)	RETFGFR1FLT1KDRPDGFRA
	Dimethylamine SCHEMBL5823364	0.78	RET (0.59)	RETFGFR1FLT1KDRPDGFRA
	SCHEMBL3538752	0.78	FGFR1 (0.64)	RETFGFR1FLT1KDRPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.